Forging translational glycobiologists: intermeshing glycoscience training and clinical education

Ended Project Grant Awarded Last action

Award ID
K12HL141953
Recipient
Awarding agency
Obligated
$7,738,455

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $6,779,987.57 Federal
  • $958,467.00 Non-federal
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$899,468 $0
Amendment $958,467 $0
Amendment $958,467 $0
Amendment $958,467 $0
Amendment $958,467 $0
Amendment $958,467 $958,467
Amendment $958,467 $0
Amendment $958,467 $0
Original award $970,187 $0

Subawards

Subrecipient Amount Awarded
Dana-Farber Cancer Institute, Inc. Most adults with B-cell acute lymphoblastic leukemia (B-ALL) relapse after achieving complete remission, and nearly 20% have primary refractory disease. While… $318,421
The General Hospital Corporation Nearly 80% of lungs that are donated for transplant by patients and their families are ultimately not able to be used for the end goal of transplantation (Punch… $374,968
Florida International University Project Title: The Role of FUT2 Repression in EGFR Signaling Project Period: 9/28/2020 – 9/2022 Objective: There is a critical need to determine how… $161,373
Florida International University The goal of this investigation will be to characterize the glycocalyx of aMSC-derived exosomes via exofucosylation and lectin binding, observe if their uptake… $471,637
Beth Israel Deaconess Medical Center, Inc. During the duration of the K12 grant, Dr. Cheng will develop an understanding of the presence of Tn expression, by developing technological tools to analyze the… $191,145
Beth Israel Deaconess Medical Center, Inc. Title of Project: Podoplanin Glycopeptide Mimetics for Treatment of Venous Thrombosis Podoplanin (PDPN) is a transmembrane sialoglycoprotein with extensive… $423,783
Beth Israel Deaconess Medical Center, Inc. The purpose of this project is to identify changes in glycosylation associated with pancreatic ductal adenocarcinoma compared to normal pancreas using human… $167,832
The General Hospital Corporation Over 20% of the world's population suffers from one or more allergic conditions including asthma, rhinitis, eczema, and food allergies. These diseases arise… $550,503
Beth Israel Deaconess Medical Center, Inc. Elliot L. Chaikof, MD, PhD in the Department of Surgery at Beth Israel Deaconess Medical Center, will serve as a participating faculty mentor in the K12… $134,180

Quick answers

Who received award K12HL141953?

K12HL141953 was awarded to Brigham & Womens Hospital Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2018.

How much is award K12HL141953 worth?

$7,738,455 has been obligated on K12HL141953: $6,779,988 in federal funding and $958,467 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login